Is it justified to exclude patients with minor stroke from intravenous thrombolysis?

Int J Stroke. 2013 Apr;8(3):E4. doi: 10.1111/j.1747-4949.2012.00847.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Fibrinolytic Agents / administration & dosage*
  • Humans
  • Infusions, Intravenous
  • Patient Selection*
  • Recombinant Proteins / administration & dosage
  • Severity of Illness Index
  • Speech Disorders / etiology*
  • Stroke / drug therapy*
  • Tissue Plasminogen Activator / administration & dosage*

Substances

  • Fibrinolytic Agents
  • Recombinant Proteins
  • Tissue Plasminogen Activator